This inventor holds 1 USPTO granted patent. Top assignee: Merck Frosst Canada & Co.. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: David Claveau: Innovator in Biochemical Assays
Introduction
David Claveau is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of biochemistry, particularly in the development of assays that are crucial for understanding cellular processes.
Latest Patents
David Claveau holds a patent for a "Whole cell assay for cathepsin K activity." This invention is instrumental in determining cathepsin K activity in mammalian cell systems. It also plays a vital role in identifying and evaluating inhibitors of cathepsin K, which can have implications in various therapeutic areas.
Career Highlights
David Claveau is associated with Merck Frosst Canada & Co., a leading pharmaceutical company. His work there has allowed him to focus on innovative solutions that advance the understanding of biochemical pathways.
Collaborations
Some of his notable coworkers include Joseph A Mancini and Denis Riendeau. Their collaborative efforts contribute to the success of the projects they undertake.
Conclusion
David Claveau's work in developing a whole cell assay for cathepsin K activity showcases his innovative spirit and dedication to advancing biochemistry. His contributions are valuable to the scientific community and have the potential to impact therapeutic developments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile